Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × venetoclax × Other neoplasm × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12 Lymphoid 3 Myeloid 2 Other neoplasm 1 Classical hematology 1

Conditions

Older Patients 1

Interventions

Decitabine 4 Busulfan 3 Cyclophosphamide 2 venetoclax 1 fludarabine 1 Paclitaxel 1 Influenza Vaccines 1 Celecoxib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡